<?xml version='1.0' encoding='utf-8'?>
<document id="28876170"><sentence text="Transgender Women Living with HIV Frequently Take Antiretroviral Therapy and/or Feminizing Hormone Therapy Differently Than Prescribed Due to Drug-Drug Interaction Concerns." /><sentence text="Both hormone therapy (HT) and antiretroviral therapy (ART) can be lifesaving for transgender women (TW) living with HIV, but each has side effects and potential drug-drug interactions (DDI)" /><sentence text=" We assessed how concerns about HT-ART interactions affect treatment adherence" /><sentence text="" /><sentence text="This study used a cross-sectional survey of TW (n = 87) in Los Angeles, CA" /><sentence text="" /><sentence text="Fifty-four percent were living with HIV; 64% used HT" /><sentence text=" Only 49% of TW living with HIV discussed ART-HT DDI with their provider; 40% reported not taking ART (12%), HT (12%), or both (16%) as directed due to DDI concerns"><entity charOffset="109-111" id="DDI-PubMed.28876170.s8.e0" text="HT" /><entity charOffset="46-47" id="DDI-PubMed.28876170.s8.e1" text="HT" /><pair ddi="false" e1="DDI-PubMed.28876170.s8.e1" e2="DDI-PubMed.28876170.s8.e1" /><pair ddi="false" e1="DDI-PubMed.28876170.s8.e1" e2="DDI-PubMed.28876170.s8.e0" /></sentence><sentence text="" /><sentence text="Imperfect HT/ART use and limited provider communication suggests a need for improved HT-ART integration"><entity charOffset="10-11" id="DDI-PubMed.28876170.s10.e0" text="HT" /><entity charOffset="85-86" id="DDI-PubMed.28876170.s10.e1" text="HT" /><pair ddi="false" e1="DDI-PubMed.28876170.s10.e0" e2="DDI-PubMed.28876170.s10.e0" /><pair ddi="false" e1="DDI-PubMed.28876170.s10.e0" e2="DDI-PubMed.28876170.s10.e1" /></sentence><sentence text="" /></document>